# Evaluation of HQ® Matrix Soft Tissue Mesh for the Treatment of Inguinal Hernia

> **NCT02487628** · NA · UNKNOWN · sponsor: **Zhejiang Xingyue Biotechnology Co., Ltd.** · enrollment: 144 (estimated)

## Conditions studied

- Inguinal Hernia

## Interventions

- **DEVICE:** HQ® Matrix Soft Tissue Mesh
- **DEVICE:** ULTRAPRO® Partially Absorbable Lightweight Mesh

## Key facts

- **NCT ID:** NCT02487628
- **Lead sponsor:** Zhejiang Xingyue Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2016-06
- **Final completion:** 2016-12
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2015-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02487628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02487628, "Evaluation of HQ® Matrix Soft Tissue Mesh for the Treatment of Inguinal Hernia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02487628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*